Inventor · disambiguated record
Kahan Leong
Also filed as: LEONG KAHAN
21 granted patents·4 pending applications·515 citations·filing 1999–2011
96Inventor score
Top patents by PatentIndex Score
25 records- 0198US6329503B1Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 1999·Granted Dec 11, 2001·147 cites·16 claims
- 0296US7053186B2Antibodies immunospecific for STEAP1AGENSYS INC·Filed 2001·Granted May 30, 2006·48 cites·7 claims
- 0395US8414898B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAFAR DANIEL E·Filed 2011·Granted Apr 9, 2013·35 cites·24 claims
- 0494US7928201B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Apr 19, 2011·16 cites·20 claims
- 0594US7642054B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2005·Granted Jan 5, 2010·19 cites·21 claims
- 0694US7611904B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2006·Granted Nov 3, 2009·19 cites·39 claims
- 0794US7166714B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2003·Granted Jan 23, 2007·35 cites·6 claims
- 0894US6887975B2Peptides derived from STEAP1AGENSYS INC·Filed 2001·Granted May 3, 2005·40 cites·8 claims
- 0993US7968307B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2009·Granted Jun 28, 2011·14 cites·22 claims
- 1092US6943235B1Transmembrane protein expressed in prostate cancerAGENSYS INC·Filed 2000·Granted Sep 13, 2005·34 cites·10 claims
- 1191US7037667B1Tumor antigen useful in diagnosis and therapy of prostate and colon cancerAGENSYS INC·Filed 2000·Granted May 2, 2006·41 cites·10 claims
- 1289US7575749B2Serpentine transmembrane antigens expressed in human cancers and uses thereofAGENSYS INC·Filed 2004·Granted Aug 18, 2009·18 cites·3 claims
- 1376US8383777B213-transmembrane protein expressed in prostate cancerAGENSYS INC·Filed 2007·Granted Feb 26, 2013·2 cites·8 claims
- 1475US7306796B213-transmembrane protein expressed in prostate cancerAGENSYS INC·Filed 2002·Granted Dec 11, 2007·7 cites·8 claims
- 1575US6277972B1BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cellsUROGENESYS INC·Filed 1999·Granted Aug 21, 2001·30 cites·10 claims
- 1672US7220823B2Transmembrane protein expressed in prostate and other cancersAGENSYS INC·Filed 2002·Granted May 22, 2007·5 cites·6 claims
- 1771US7227008B213-transmembrane protein expressed in prostate cancerAGENSYS INC·Filed 2004·Granted Jun 5, 2007·5 cites·9 claims
- 1861US7981624B2Methods to detect tumors using 20P1F12/TMPRSS2 expressionAGENSYS INC·Filed 2009·Granted Jul 19, 2011·0 cites·3 claims
- 1959US7785811B2BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cellsAGENSYS INC·Filed 2005·Granted Aug 31, 2010·0 cites·14 claims
- 2056US8003758B2BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cellsAGENSYS INC·Filed 2010·Granted Aug 23, 2011·0 cites·1 claims
- 2155US7858760B2Antibodies to protein expressed in prostate cancerAGENSYS INC·Filed 2004·Granted Dec 28, 2010·0 cites·17 claims
- 2251US2002161212A1BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cellsFiled 2001·Application pending·0 cites
- 2349US2005239122A1Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancerAFAR DANIEL E·Filed 2005·Application pending·0 cites
- 2446US2004265310A1Novel prostate-restricted gene expressed in prostate cancerFiled 2004·Application pending·0 cites
- 2543US2006275304A1Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancerAGENSYS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kahan Leong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →